G. Cakan-Akdogan Et Al. , "An in vivo zebrafish model reveals circulating tumor cell targeting capacity of serum albumin nanoparticles," JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.75, 2022
Cakan-Akdogan, G. Et Al. 2022. An in vivo zebrafish model reveals circulating tumor cell targeting capacity of serum albumin nanoparticles. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.75 .
Cakan-Akdogan, G., Ersoz, E., Sozer, S. C., & Gelinci, E., (2022). An in vivo zebrafish model reveals circulating tumor cell targeting capacity of serum albumin nanoparticles. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.75.
Cakan-Akdogan, GÜLÇİN Et Al. "An in vivo zebrafish model reveals circulating tumor cell targeting capacity of serum albumin nanoparticles," JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.75, 2022
Cakan-Akdogan, GÜLÇİN Ç. Et Al. "An in vivo zebrafish model reveals circulating tumor cell targeting capacity of serum albumin nanoparticles." JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.75, 2022
Cakan-Akdogan, G. Et Al. (2022) . "An in vivo zebrafish model reveals circulating tumor cell targeting capacity of serum albumin nanoparticles." JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.75.
@article{article, author={GÜLÇİN ÇAKAN AKDOĞAN Et Al. }, title={An in vivo zebrafish model reveals circulating tumor cell targeting capacity of serum albumin nanoparticles}, journal={JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY}, year=2022}